The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...
Provepharm said it pulled lot No. 24020027 with December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/mL after ...
Hydrochloride for Injection, USP in two vial sizes: 25 mg/1 mL and 50 mg/2 mL, further broadening PCC's increasing portfolio of generic injectables.
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...
My choice for the best 40-inch TV is the Samsung QN90D for its updated QLED panel, which provides a brighter picture along with deeper contrast and bolder colors. It also features support for both ...
Evans has demonstrated dynamic leadership as managing director at Zeno Singapore, driving client wins, revenue growth, and championing team welfare and women’s advancement in just eight months.
PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month ...
But do these positive changes reflect on the quality of care, and do patients benefit from AI and ML-powered solutions? In this article, I share my take on the transformative potential of AI and ...
The drugs listed are in alphabetical order. Bendamustine hydrochloride injection: Apotex on Jan. 27 reported the discontinuation of both the 25 mg and 100 mg presentations of bendamustine ...
Anyone working in metro Indianapolis — including Marion and the surrounding counties — and who is under 40 on April 11, 2025, the day a special publication featuring the class is published.
ML.NET is a cross-platform open-source machine learning (ML) framework for .NET. ML.NET allows developers to easily build, train, deploy, and consume custom models in their .NET applications without ...